Double-filtration plasmapheresis reduces type I interferon bioavailability and inducing activity in systemic lupus erythematosus
Type I interferons (IFN-Is) play a significant role in systemic lupus erythematosus (SLE) pathogenesis. Double-filtration plasmapheresis (DFPP) is a treatment option for SLE; however, its effect on IFN-Is remains unclear. Therefore, we investigated the effects of DFPP on IFN-Is. Plasma from patients...
Saved in:
| Main Authors: | Takumi Saito, Ryo Takatsuji, Goh Murayama, Yu Yamaji, Yukitomo Hagiwara, Yujin Nishioka, Taiga Kuga, Tomoko Miyashita, Makio Kusaoi, Naoto Tamura, Ken Yamaji |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-10-01
|
| Series: | Immunological Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/25785826.2024.2372918 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myeloid cells as IFNα producers in systemic lupus erythematosus
by: Taiga Kuga, et al.
Published: (2025-07-01) -
Selective Removal of Plasma Proteins by Double-Filtration Plasmapheresis in Canine Blood: An Ex Vivo Study and Retrospective Report of In Vivo Clinical Treatments in Three Dogs
by: Roberta Troia, et al.
Published: (2025-05-01) -
Research the effect of 4℃ refrigerated stored apheresis platelets based on platelet metabolomics
by: XIA Xiaoye, et al.
Published: (2025-04-01) -
Estimation of serum calcium levels in apheresis platelet donors
by: P. Arpitha, et al.
Published: (2024-01-01) -
Therapeutic Apheresis in Glomerular Diseases after Kidney Transplantation
by: Maurizio Salvadori, et al.
Published: (2020-05-01)